Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Assessment of Cardiovascular Risk Markers in Growth Hormone Deficient Patients With Nonsecreting Pituitary Adenomas

This study has been terminated.
(Poor enrollment)
Sponsor:
Collaborators:
EMD Serono
Genentech, Inc.
Information provided by:
Columbia University
ClinicalTrials.gov Identifier:
NCT00646308
First received: March 25, 2008
Last updated: April 22, 2011
Last verified: April 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2010
  Primary Completion Date: January 2010 (Final data collection date for primary outcome measure)